At a glance
ob体育 works with the U.S. Food and Drug Administration (FDA); state, territorial, and local health departments; and Human Cells, Tissues, or Cellular or Tissue-based Products (HCT/P) establishments to help ensure the safety of the HCT/P supply.
What to know
On May 20, 2024, the FDA withdrew the “Guidance for Industry, Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products (Updated May 2018).” Please access the following website for further information regarding withdrawal: .
To access archived HCT/P donor screening information used prior to the date of withdrawal, please access these websites:
- (archived)